Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Doxorubicin and Vinorelbine in Metastatic Breast Cancer
NCT06653972Phase 2Not yet recruiting
- Start
- Nov 2024
- Primary completion
- Feb 2026
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of doxorubicin, vinorelbine. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
doxorubicinvinorelbine
Beyond the preview
Go deeper on NCT06653972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653972.